SRPT
Sarepta Therapeutics, Inc. · Healthcare
President and CEO Douglas S Ingram bought $2.0M of Sarepta Therapeutics, Inc.
Bought$1,999,965
$42.50Price
47,058Shares
+14%Stake
What SRPT did for a copier
Prices for SRPT after this filing aren't in yet.
Douglas S Ingram's record
6 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jul 27. Filed Fri, Jul 28, 4:51 AM ET, before the open. Not investment advice.